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The traditional Japanese phytomedicine rikkunshito is traditionally used for the treatment
of gastrointestinal motility disorders, cachexia and nausea. These effects indicate
5-HT3 receptor antagonism, due to the involvement of these receptors in such
pathophysiological processes. E.g., setrons, specific 5-HT3 receptor antagonists are the
strongest antiemetics, developed so far. Therefore, the antagonistic effects of the eight
rikkunshito constituents at heterologously expressed 5-HT3Areceptors were analyzed
using the two-electrode voltage-clamp technique. The results indicate that tinctures from
Aurantii, Ginseng, Zingiberis, Atractylodis and Glycyrrhiza inhibited the 5-HT3A receptor
response, whereas the tinctures of Poria cocos, Jujubae and Pinellia exhibited no effect.
Surprisingly, the strongest antagonism was found for Glycyrrhiza, whereas the Zingiberis
tincture, which is considered to be primarily responsible for the effect of rikkunshito,
exhibited the weakest antagonism of 5-HT3A receptors. Rikkunshito contains various
vanilloids, ginsenosides and flavonoids, a portion of which show an antagonistic effect
on 5-HT3 receptors. A screening of the established ingredients of the active rikkunshito
constituents and related substances lead to the identification of new antagonists within
the class of flavonoids. The flavonoids (-)-liquiritigenin, glabridin and licochalcone A from
Glycyrrhiza species were found to be the most effective inhibitors of the 5-HT-induced
currents in the screening. The flavonoids (-)-liquiritigenin and hesperetin from Aurantii
inhibited the receptor response in a non-competitive manner, whereas glabridin and
licochalcone A exhibited a potential competitive antagonism. Furthermore, licochalcone
A acts as a partial antagonist of 5-HT3A receptors. Thus, this study reveals new 5-HT3A
receptor antagonists with the aid of increasing the comprehension of the complex effects
of rikkunshito.
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Introduction
The 5-HT3 receptor channels are the only ionotropic receptors
within the 5-HT receptor family and belong to the cys-loop
family of ligand-gated ion channels (Derkach et al., 1989; Hannon
and Hoyer, 2008). These channels occur in the PNS and are
highly expressed in the trigeminus (Manteniotis et al., 2013) and
the enteric nervous system (Niesler et al., 2003). In the CNS,
they are expressed in the striatum, substantia nigra, amygdala,
hippocampus and nucleus accumbens (Boess and Martin, 1994).
Other 5-HT3 receptor expressing structures are the nucleus
tractus solitarius and the area postrema (Boess andMartin, 1994),
which are parts of the vomiting center that trigger nausea and
vomiting.
5-HT3 receptors are involved in many pathophysiological
processes, such as nociception and gastrointestinal motility
disorders, and the development of nausea and vomiting,
therefore showing broad clinical relevance (Doak and Sawynok,
1997; Gershon, 2004; Jeggo et al., 2005; Costedio et al., 2007).
Specific 5-HT3 receptor antagonists, such as ondansetron, are
mainly used for the treatment of nausea in various conditions,
such as chemotherapy-induced nausea and vomiting (CINV),
and nausea during the postoperative phase (PONV) (Cubeddu
et al., 1994; Gyermek, 1995).
Many 5-HT3 receptor antagonists have been identified to date.
In addition to the competitively acting setrons (Hope et al.,
1996), non-competitive antagonists have been identified within
the family of cannabinoids, such as 19-THC, anandamide and
cannabidiol (Barann et al., 2002). Moreover, steroids (Barann
et al., 1999) and the anesthetics ketamine, propofol, methohexital
and pentobarbital (Barann et al., 1993, 2000a,b, 2008) have been
shown to antagonize 5-HT3 receptors. Many plant compounds
also act as 5-HT3 receptor antagonists. For example, alkaloids,
such as nicotine (Schreiner et al., 2014), hot substances and
terpenes, e.g., bilobalide and ginkgolide B (Thompson et al.,
2011), gingerols (Walstab et al., 2013) and many others, were
reviewed by Walstab et al. (2010).
Kampo is a traditional Japanese phytomedicine that has
its seeds in traditional Chinese medicine. Rikkunshito, a
combination of eight constituents, is one of the most famous
and prescribed kampo medicines (Tominaga and Arakawa,
2015), and it has a well-known physiological effect on the
gastrointestinal system, shows orexigen and antiemetic effects,
and takes part in the regulation of peristalsis (Takeda et al., 2008;
Tominaga et al., 2011; Yanai et al., 2013; Fujitsuka and Uezono,
2014). These effects indicate an antagonism of 5-HT3 receptors.
Therefore, the antagonistic effects of the eight constituents of
rikkunshito (Aurantii pericarpium, Ginseng radix, Zingiberis
rhizoma, Jujubae (Zizyphi) frucutus, Pinellia tuber, Atractylodis
rhizoma, Glycyrrhiza radix and Poria cocos (Hoelen) were
investigated as ethanol tinctures. Furthermore, we investigated
the established ingredients of the active rikkunshito constituents
to identify new 5-HT3A receptor antagonists. Although the
antagonistic and hence the antiemetic effect of Ginseng and
Zingiberis due to the action of ginsenosides, gingerols and
shogaols is well-described (Ernst and Pittler, 2000; Kim et al.,
2005; Lee et al., 2007; Haniadka et al., 2012; Ding et al., 2013),
there is currently little knowledge of the effect of the residual
rikkunshito constituents on 5-HT3 receptors.
The aim of this study was the evaluation of the relative
contribution of the single constituents of rikkunshito to
5-HT3 receptor antagonism and the identification of new
antagonists. Therefore, we tested the modulatory effect of
tinctures and single substances on heterologously expressed
human 5-HT3A receptors using the two-electrode voltage-
clamp technique. Surprisingly, Glycyrrhiza was identified as
the most effective antagonistic tincture among the rikkunshito
constituents. Therefore, we concentrated on the investigation of
Glycyrrhiza ingredients and identified several new flavonoids as
5-HT3A receptor antagonists. The drug Radix Glycyrrhiza is used
in Kampo medicine for the treatment of pain, gastric ulcers and
inflammations of the gastrointestinal and respiratory systems due
to its antiphlogistic effect (Kim et al., 2008). A contribution of
Radix Glycyrrhiza to the antiemetic effect of rikkunshito due to
the action of flavonoids is conceivable.
Materials and Methods
Expression System
The expression plasmid contains the cDNA coding for the 5-
HT3A protein in pcDNA3 (Invitrogen) (Lobitz et al., 2001).
cRNAs were prepared using the AmpliCap T7 high-yieldmessage
marker kit (Epicenter, Madison, WI, USA), following the
manufacturer’s protocol. Xenopus laevis oocytes were obtained as
previously described (Sherkheli et al., 2010) and injected with a
total amount of 7–20 ng of the receptor-coding cRNA using an
injection-setup fromWPI (Nanoliter 2000, Micro4). The injected
oocytes were stored in ND 96 (96.0mM NaCl, 2.0mM KCl,
1.8mMCaCl2, 1.0mMMgCl2, 5.0mMHEPES, pH 7.2, 200U/ml
penicillin, and 200µg/ml streptomycin) at 17◦C. Measurements
were performed one to 5 days after cRNA injection.
Electrophysiology
The electrophysiological recordings were performed using the
two-electrode voltage-clamp technique as previously described
(Saras et al., 2008). All of the measurements were performed
in normal frog ringer (NFR) [115mM NaCl, 2.5mM KCl,
1.8mM CaCl2, 10mM HEPES; pH 7.2 (NaOH/HCl)] containing
niflumic acid (NA) (100µM) to block the Ca2+-induced currents
mediated by the intrinsic chloride channel (TMEM16A) or
under Ca2+-free conditions [115mMNaCl, 2.5mMKCl, 1.8mM
MgCl2, 10mM HEPES; pH 7.2 (NaOH/HCl)]. All of the
substances were applied after preincubation (30 s). The currents
were recorded at a holding potential of typically −60mV using
the Cell Works 6.1.1. software (NPI).
Solvent Controls
To exclude any unrequested effects of the solvents ethanol
and DMSO, we tested their direct activation on non-injected
and 5-HT3A receptor-expressing oocytes. At the maximal used
concentration (1Vol.-%), a negligible direct activation was
observed. Moreover, the modulatory effect on the 5-HT3A
receptor response was tested at concentrations of 1.0Vol.-% for
ethanol and DMSO. Ethanol exhibited an inhibition of 14.1 ±
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2.6%, and DMSO exhibited an inhibition of 29.1 ± 4.7% (n =
6 − 11). Equivalent volumes of ethanol and DMSO were added
to the reference 5-HT solutions. To resolve glycyrrhizin, the
solution had to be acidified (pH 5.5). Therefore, we checked
the modulatory effect of the pH values on 5-HT3A receptors.
Low extracellular pH values inhibited the currents but high pH
showed potentiating effects (Supplementary Figure 2).
Action of the Tinctures on Non-injected Xenopus
Oocytes
In the control experiments, at a concentration of 1Vol.-%, the
tinctures of Ginseng, Zingiberis and Atractylodis evoked currents
in some non-injected oocytes with desensitizing responses (data
not shown). In our experiments with 5-HT3A receptor-expressing
cells, oocytes were rejected if the amplitude of this direct
activation was greater than 10% of the 5-HT-induced current;
thus, the direct action of the extracts could not prevent the
identification of pronounced blocking effects. Moreover, in our
blocking experiments, these currents were desensitized during
the 30-s preincubation with the tincture. At a concentration of
0.1 Vol.-%, none of the tinctures evoked any current different
from that obtained from the control application of Ringer‘s
solution.
Evaluation of Competitive and Non-competitive
Antagonists
To determine the apparent mode of antagonism of the identified
tinctures and substances with antagonistic effects, we tested
the inhibition of currents induced by low (2.5µM) and high
(30µM) 5-HT concentrations. In the case of a non-competitive
mechanism, the inhibition should be independent of the 5-HT
concentration, whereas the efficacy of competitive antagonists
decreases with increasing 5-HT concentrations. Alternatively to
a competitive mechanism, the dependence of the inhibition on
the agonist concentration can also be caused by an allosteric
modulation. As a control, we tested the competitive antagonists
ondansetron (1 nM) and d-tubocurarine (20µM) (Hope et al.,
1996) and the non-competitive antagonist picrotoxin (50µM)
(Das and Dillon, 2005). As expected, the inhibition of picrotoxin
was independent of the 5-HT concentration, and the inhibition
obtained with d-tubocurarine and ondansetron was reduced
at higher 5-HT concentrations (Table 1). Thus, the method
used may indicate the mode of antagonism. Nevertheless, a
definitive differentiation between competitive, allosteric, and
concentration-dependent antagonists must be performed using
ligand binding assays.
Tinctures and Substances
Ethanol tinctures of the rikkunshito constituents were obtained
from Dr. Peter Lepke (Kronen Apotheke Wuppertal, Germany).
Thus, plant preparations at appropriate quality for Japanese
kampo medicine were extracted [200 g crushed plant material in
1 l ethanol (45–90% v/v)] for 10 days at room temperature. The
tinctures were obtained by filtrating the supernatant, therefore
containing no large solid parts of the plants. The dry weight of
the extracted substances was determined by removing the solvent
under vacuum (Supplementary Table 2). We used the following
tinctures in our study:
Aurantii Pericarpium [Citrus reticulata Blanco (Rutaceae)]
(chinpi, Chen Pi),WhiteGinseng Radix [Panax ginseng C.A.Mey.
TABLE 1 | Competitive and non-competitive action of the identified antagonists and tinctures with antagonistic effect.
Tincture/Substance Concentration Mean inhibition ± SEM [%] Significance level/mode of antagonism
5-HT [2.5µM] 5-HT [30µM]
CONTROLS
Picrotoxin 50µM 72.5 ± 3.7 73.0 ± 2.8 ns/nc
D-tubocurarine 20µM 82.0 ± 3.5 45.9 ± 4.8 **/c
Ondansetron 1 nM 82.4 ± 3.4 57.9 ± 5.3 */c
TINCTURES
Zingiberis 1Vol.-% 20.1 ± 4.9 22.2 ± 4.2 ns/nc
Aurantii 1Vol.-% 37.3 ± 5.4 28.8 ± 2.6 ns/nc
Ginseng 1Vol.-% 44.6 ± 8.7 36.6 ± 7.3 ns/nc
Atractylodis 1Vol.-% 47.1 ± 5.6 27.4 ± 9.1 */c
Glycyrrhiza 1Vol.-% 64.5 ± 9.7 69.1 ± 7.4 ns/nc
Unsweetened licorice 1 Vol.-% 44.6 ± 5.7 13.7 ± 6.6 ***/c
SUBSTANCES
Atractylenolide III 1mM 55.0 ± 6.2 57.8 ± 6.0 ns/nc
Licochalcone A 1mM 76.1 ± 6.1 58.7 ± 2.6 */c
Glabridin 100µM 64.7 ± 2.1 17.3 ± 2.3 ***/c
Hesperetin 1mM 77.3 ± 9.0 79.7 ±6.1 ns/nc
(-)-liquiritigenin 0.5mM 84.5 ± 2.4 93.5 ± 0.5 */nc
The inhibitions of the 5-HT3A receptor responses by the controls (picrotoxin, ondansetron and d-tubocurarine) and different tinctures and substances at 5-HT concentrations of 2.5
and 30µM are shown. The level of significance between the inhibitions obtained with two different 5-HT concentrations is indicated by asterisks in the last column (ns, not significant).
Furthermore, the apparent mode of antagonism is listed in the last column (c, apparently competitive; nc, non-competitive) (n = 5–7).
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(Araliaceae)] (ninjin, Ren Shen), Zingiberis viridis Rhizoma
[Zingiber officinale Roscoe (Zingiberaceae)] (shôkyô, Sheng
Jiang), Jujubae Fructus [Ziziphus jujuba Mill. (Rhamnaceae)]
(taisô, Da Zao), Pinelliae Tuber (Pinellia ternata [Thunb.)
Makino (Araceae)] (hange, Ban Xia), Atractylodis macrocephala
Rhizoma [Atractylodes macrocephala Koidz. (Asteraceae)]
(sôjutsu, Bai Zhu), Glycyrrhiza Radix [Glycyrrhiza uralensis
Fisch. (Fabaceae)] (kanzô, Gan Cao) and Poria cocos [Wolfiporia
extensa (Peck) Ginns (Polyporaceae)] (bukuryô, Fu Ling).
Unsweetened licorice (Liquirizia purissima from R. De
Rosa, Italy) was inlayed in ethanol (70% v/v) under the
same conditions. The chemicals were obtained from Sigma
Aldrich (5-HT hydrochloride, niflumic acid (blocker for Ca2+
activated chloride channels), picrotoxin (non-competitive ion
channel blocker), d-tubocurarine (competitive nACh and 5-
HT3 receptor antagonist), ondansetron (specific, competitive
5-HT3 receptor antagonist), (-)-liquiritigenin, licochalcone A,
hesperidin, hesperetin, glabridin and glycyrrhizin), Carl Roth
(rutin) and PhytoLab (atractylenolide III). The substances were
diluted in water, dimethyl sulfoxide (DMSO) or ethanol.
Data Analysis
The test substances were applied in an alternating manner
with 5-HT. Therefore, the currents of the test substances or
the modulated currents were normalized to the mean of the
5-HT-induced currents before and after the test substance was
applied. The concentration-response data were fitted with the
Hill equation with variable slope using SigmaPlot 8.0 (SPSS).
Thereby, the calculation of the EC50 and IC50-values was
done. The deviations are represented by the standard error
of the mean (SEM). The datasets were tested for statistically
significant differences through Student’s t-test using Excel 2010
(Microsoft) (∗p < 0.05; ∗∗p < 0.005; ∗∗∗p < 0.0005). For
multiple comparisons, the significance levels were corrected via
Bonferroni-correction.
Results
Effect of Tinctures of Rikkunshito Constituents
The gastroprokinetic and antiemetic effects of rikkunshito
(Tominaga et al., 2011) could be explained by an antagonism
of 5-HT3A receptors. To test this hypothesis, we tested the
modulatory effects of the constituents of rikkunshito on the
5-HT3A responses. In the first experiments, we tested the effect of
the respective tinctures to provide guidance for the identification
of the most effective constituents. Under our experimental
conditions an EC50 value for 5-HT of 2.39 ± 0.06µM was
determined for the 5-HT3A receptor (Supplementary Figure 1).
This EC50 value is similar to previously reported EC50 values
evaluated in Xenopus oocytes (about 2µM 5-HT) (Lee et al.,
2008; Schreiner et al., 2014). The tinctures from rikkunshito
and its constituents Aurantii, Ginseng, Zingiberis, Atractylodis,
and Glycyrrhiza, inhibited the 5-HT3A receptor responses (5-HT
2.5µM, approximately EC50) at a concentration of 1Vol.-%,
whereas the tinctures of Poria cocos, Jujubae and Pinellia
exhibited no effect (Figure 1A). Among the five tinctures that
exerted an inhibitory effect, the tincture of Glycyrrhiza showed
the strongest inhibition (84.6 ± 1.4%) (Figure 1B), and the
weakest effect was obtained with the Zingiberis tincture (24.9
± 2.6%). The inhibition obtained with the rikkunshito tincture
(33.7 ± 1.5%) was close to that calculated by the addition
of the effects of the tinctures of the eight constituents with
regard to their mass distribution in the decoction (27.5%)
(Supplementary Table 1). The 5-HT3A receptor responses
FIGURE 1 | Inhibition of 5-HT3A receptors by tinctures of rikkunshito
and its constituents (A) and original traces from the inhibition by the
Glycyrrhiza tincture (B,C). (A) The dark bars represent the inhibition at
1 Vol.-%, and the bright bars represent that at a concentration of 0.1 Vol.-%.
The inhibition from left to right are as follows: 33.7 ± 6.8%, 1.5 ±
7.6%, −0.7±10.7%, −0.7±4.8%, −12.0±4.5%, 24.9 ± 2.6%, 6.5 ± 2.2%,
45.1 ± 4.6%, −9.2± 7.3%, 55.9 ± 2.8%, 5.8 ± 4.3%, 58.3 ± 8.1%; 8.4 ±
5.7%, 84.6 ± 1.4% and 26.6 ± 4.4% (n = 5− 8) (*p < 0.05; **p < 0.005;
***p < 0.0005). (B,C) The time of application is denoted by the application
bars above the trace. The inhibition was reversible after a 150-s washout
(holding potential = −60mV). (C) The 5-HT-induced currents showed a
characteristic rebound when co-applied with the Glycyrrhiza tincture.
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showed a huge rebound when co-applied with Glycyrrhiza
(Figure 1C). All of the six inhibitory tinctures were also tested
at a lower concentration (0.1Vol.-%). In these experiments, only
the tincture of Glycyrrhiza showed a significant inhibition (26.6
± 4.4%) (Figure 1A). All of the inhibitions were reversible after
a 150-s washout.
Modulatory Effect of the Rikkunshito Ingredients
and Tincture of Unsweetened Licorice
The tinctures contain many different chemical substances. To
identify the active compounds, we assessed the modulatory
effects of some known ingredients of these plants on 5-HT3A
receptors. We focused on the ingredients of Glycyrrhiza uralensis
that showed the strongest antagonism within the rikkunshito
constituents and other ingredients of further Glycyrrhiza species.
Thus, we tested a tincture of unsweetened licorice because it
is obtained from Glycyrrhiza glabra L. (Fabaceae). We used
a concentration of 1mM for all of the substances with the
exception of glabridin (100µM) and 1Vol-% for the licorice
tincture.
Four ingredients of Glycyrrhiza species were investigated.
Glycyrrhizin and the flavonoid (-)-liquiritigenin are ubiquitous
within the plants of the genusGlycyrrhiza, whereas the flavonoids
glabridin and licochalcone A are restricted to G. glabra and
G. inflata and G. eurycarpa (Xu et al., 1997; Rauchensteiner et al.,
2005; Kondo et al., 2007). Glycyrrhizin exhibited no modulatory
effect (−3.1 ± 4.3%), whereas glabridin revealed an inhibition
of 62.8 ± 2.1%. Licochalcone A and (-)-liquiritigenin were the
most effective antagonists, showing inhibitions of 70.6 ± 3.1%
and 92.8 ± 2.2%, respectively (Figure 2A). Other flavonoids
found in Aurantii, namely hesperetin and rutin, also exhibited
antagonistic effects. Hesperidin, the most abundant ingredient
in rikkunshito (Tominaga et al., 2011), revealed no effect. The
flavonoids hesperetin and (-)-liquiritigenin caused 5-HT-induced
responses with huge rebounds, similar to those obtained with the
Radix Glycyrrhiza uralensis tincture (compare Figures 1C, 2B).
The tincture of the unsweetened licorice caused an inhibition of
5-HT-induced currents of 35.5± 5.7%.
Competitive and Non-competitive Action of the
Identified Antagonists
The tinctures of Atractylodis and unsweetened licorice, as well as
glabridin and licochalcone A, exhibited an apparent competitive
antagonism. The tincture of Zingiberis and Glycyrrhiza and (-)-
liquiritigenin showed increased inhibition at the higher agonist
concentration (30µM), indicating a non-competitive blocking
mechanism (Table 1).
Concentration-inhibition Curves of the Identified
Antagonists
To characterize and quantify the action of the identified
antagonists, we generated concentration-inhibition curves using
5µM 5-HT. The tinctures inhibited the 5-HT3A receptor
responses with regard to their IC50 values expressed as Vol.-%
in the following order: Glycyrrhiza (0.281 ± 0.051) > Ginseng
(0.481 ± 0.046) > Atractylodis (0.685 ± 0.028) > Aurantii
(0.774 ± 0.096) > Zingiberis (1.517 ± 0.869) (Figure 3A).
This ranking order was identical to that obtained previously
(Figure 1A). The potency of the flavonoids hesperetin (IC50 =
218± 38µM) and (-)-liquiritigenin (IC50 = 210± 25µM) were
similar (Figure 3B). The inhibition by licochalcone A stagnated
at approximately 60%, indicating that it shows characteristics of
a partial antagonist. In addition to glabridin (IC50 = 28.0 ±
2.8µM), licochalcone A showed the highest potency (IC50 =
14.4± 1.3µM) (Figures 3B,C).
Discussion
Rikkunshito is a Japanese herbal medicine that shows orexigen
and antiemetic effects (Takeda et al., 2008; Fujitsuka and
FIGURE 2 | 5-HT3A receptor inhibition by the substances and the
unsweetened licorice tincture (A) and original traces of the
antagonistic effect of hesperetin and (-)-liquiritigenin (B). (A) Of
the tested substances, the flavonoids exhibited the strongest inhibition
with hesperetin and rutin from Aurantii and licochalcone A and
(-)-liquiritigenin from Glycyrrhiza species. The inhibition from left to right
are the following: −3.1± 4.3%, −2.6± 5.3%, 55.0 ± 6.2%, 57.0 ±
6.1%, 66.6 ± 9.3%, 62.8 ± 2.1%, 70.6 ± 3.1%, 92.8 ± 2.0%, and
35.5 ± 5.7% (n = 5− 9) [tincture = 1Vol.-%, substances = 1mM
except glabridin (100µM)] (**p < 0.005; ***p < 0.0005). (B) The time of
application is denoted by the application bars above the traces. The
inhibition was reversible after a 150-s washout. The 5-HT-induced
currents showed a characteristic rebound when co-applied with
hesperetin or (-)-liquiritigenin (magnifications).
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FIGURE 3 | Concentration-inhibition curves of the antagonistic
rikkunshito tinctures (A), substances (B,C) and original traces from
the recordings of hesperetin (D), (-)-liquiritigenin (E) and licochalcone
A (F). (A) The calculated IC50 values for the tinctures are the following:
1.025 ± 0.2 Vol.-% for rikkunshito (•), 1.517 ± 0.869Vol.-% for Zingiberis (o),
0.774 ± 0.096Vol.-% for Aurantii (H), 0.685 ± 0.028Vol.-% for Atractylodis
(∇), 0.481 ± 0.046Vol.-% for Ginseng () and 0.281 ± 0.051Vol.-% for
Glycyrrhiza () (n = 4− 6). (B) The calculated IC50 values for the substances
are the following: 1322 ± 145µM for atractylenolide III (•), 218 ± 38µM for
hesperetin (o), 210 ± 25µM for (-)-liquiritigenin (H) and 28.0 ± 2.8µM for
glabridin (▽) (n = 5− 7). (C) The inhibition by licochalcone A stagnated at
59.0 ± 7.1%, resulting in a residual current of approximately 40% remaining
(dashed line). The IC50 value was 14.4 ± 1.3µM (n = 5− 8). (D–F)
Application of 5-HT + inhibitor (H) leads to currents, whose maximal
amplitude (labeled with -) decreases with increasing concentrations of the
inhibitor. The inhibition obtained with licochalcone A stagnated above a
concentration of 10µM, whereas the inhibition induced by hesperetin and
(-)-liquiritigenin showing rebounds at concentrations greater than 300µM
and increased with increases in the concentrations until nearly the whole
response was blocked.
Uezono, 2014; Tominaga and Arakawa, 2015). Moreover, it is
involved in the regulation of peristalsis and digestion (Tominaga
et al., 2011) and therefore ameliorates symptoms of functional
dyspepsia and irritable bowel syndrome (Oka et al., 2014).
These effects and the antiemetic properties of rikkunshito
may be explained by 5-HT3 receptor antagonism. Therefore,
we assessed the modulatory effect of the eight rikkunshito
constituents as ethanol tinctures to identify the most effective
constituents and to find new specific antagonists for the 5-HT3A
receptor.
We detected an antagonistic effect on 5-HT3A receptors
exerted by the tinctures of rikkunshito, Aurantii, Ginseng,
Zingiberis, Atractylodis, and Glycyrrhiza. Surprisingly, Zingiberis,
which was initially thought to be mainly responsible for the
effects of rikkunshito, was the weakest identified antagonist.
However, we identified Radix Glycyrrhiza uralensis as the
strongest 5-HT3A receptor antagonist among the tinctures
(Figures 1A, 3A), presumably through the action of (-)-
liquiritigenin.
The flavonoid glycoside hesperidin from Aurantii is one
of the most abundant flavonoids in rikkunshito. It shows a
gastroprokinetic effect similar to that of the specific 5-HT3
receptor antagonist ondansetron, suggesting that hesperidin is
a 5-HT3 receptor antagonist (Tominaga et al., 2011). However,
in our experiments, only hesperetin, the aglycone of hesperidin,
exhibited 5-HT3A receptor antagonism. Tominaga et al. used
an in vivo animal experimental paradigm in which hesperidin
was applied orally. Therefore, it is possible that hesperidin is
converted into the active substance by deglycosylation in vivo.
The lack of 5-HT3A receptor antagonism for hesperidin may be
explained by steric problems caused by glycosylation with the
disaccharide rutinose. However, other glycosylated flavonoids are
known, e.g., rutin from Aurantii, which shows an antagonistic
effect on 5-HT3 receptors. However, also in this case, quercetin,
the aglycone of rutin, is the more potent substance (Lee et al.,
2008).
The tincture of Atractylodis, which is used in kampo medicine
for the treatment of nausea and cachexia, showed a strong,
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apparently competitive antagonism. In our study, atractylenolide
III, a weak antagonist (IC50 = 1322 ± 145µM), was the only
ingredient that was investigated. However, investigations
of other ingredients, such as atractylol, atractylon or
biatractylolid (Shao et al., 2014), could lead to the identification
of competitive 5-HT3A receptor antagonists with higher
potency.
Strong 5-HT3A receptor antagonism was also observed for the
tincture of Ginseng, which is used due to its antiemetic effect.
Kim et al. showed that Ginseng extracts reduce cisplatin-induced
nausea in ferrets (Kim et al., 2005). Steroid glycosides, called
ginsenosides, are accountable for the observed 5-HT3A receptor
antagonism (Min et al., 2003; Lee et al., 2007), and their binding
site in the pore region of 5-HT3A receptors has been identified
(Lee et al., 2007).
The vanilloids gingerol and shogaol (Abdel-Aziz et al., 2005,
2006; Walstab et al., 2013) as well as the diterpene lactone
galanolactone (Huang et al., 1991) are responsible for the
antagonistic effect of the Zingiberis tincture. Abdel-Aziz et al.
showed that gingerols and shogaols inhibit the contractions of
isolated guinea pig and rat ilea induced by a specific 5-HT3
receptor agonist (Abdel-Aziz et al., 2005, 2006), indicating 5-HT3
receptor antagonism for the spasmolytic effects of Zingiberis and
rikkunshito. Our study supports the proposal of these vanilloids
as the active principles of Zingiberis due to the non-competitive
antagonism of this tincture, which was previously reported for
gingerol and shogaol (Walstab et al., 2013). Inmany clinical trials,
Zingiberis was able to reduce nausea under various conditions,
such as motion sickness, hyperemesis gravidarum, CINV and
PONV (Ernst and Pittler, 2000; Haniadka et al., 2012; Ding et al.,
2013).
Radix Glycyrrhiza is used for the treatment of gastric
ulcer and inflammations of the gastrointestinal and respiratory
system (Kim et al., 2008). Among the rikkunshito constituents,
Glycyrrhiza uralensis is the antagonistic tincture with the
highest efficacy and potency. Moreover, we tested a tincture of
unsweetened licorice, which is sourced from Glycyrrhiza glabra
and usually consumed. This tincture was also able to inhibit
the 5-HT3A receptor responses. We tested four Glycyrrhiza
ingredients, namely the glycoside glycyrrhizin and the flavonoids
glabridin, (-)-liquiritigenin and licochalcone A. Although (-)-
liquiritigenin and glycyrrhizin are ubiquitous within the plants of
the genus Glycyrrhiza, glabridin and licochalcone A are restricted
to specific species. Glabridin is a specific ingredient ofGlycyrrhiza
glabra, and licochalcone A is detectable only in the species
G. inflata and G. eurycarpa (Xu et al., 1997; Rauchensteiner
et al., 2005; Kondo et al., 2007). Glycyrrhizin, which is used
for the treatment of epilepsy, chronic gastritis and obstipation
(Hänsel et al., 1993), showed no 5-HT3A receptor antagonism.
The flavonoids glabridin, (-)-liquiritigenin and licochalcone A
exhibited the strongest antagonism among our tested substances.
(-)-Liquiritigenin appears to be the active component in
Glycyrrhiza uralensis. Both showed non-competitive antagonism
and lead to a huge rebound of the inhibited 5-HT3A receptor
responses. In addition to (-)-liquiritigenin, hesperetin exhibited
similar kinetics at high concentrations (Figures 3E,F). Because
both flavonoids are chemically related (Figure 4), possess similar
FIGURE 4 | Chemical structure of the investigated flavonoids.
Hesperetin and (-)-liquiritigenin share similar molecular structures.
IC50 values and share a non-competitive antagonism, a common
binding site at the receptor is hypothesized.
Kim et al. investigated the antiphlogistic effect of liquiritigenin
and attributed this effect to the inhibition of NF-KB, an important
transcription factor in the immune response (Kim et al., 2008).
Therefore, liquiritigenin may contribute to the antiemetic and
antiphlogistic effects of rikkunshito. In contrast, (-)-liquiritigenin
cannot be accountable for the concentration-dependent 5-
HT3A receptor antagonism of the licorice tincture. Instead, the
apparently competitive blocker glabridin, which is a potentiator
of the closely related GABAA receptor (Jin et al., 2013), may
be the main antagonist of the unsweetened licorice, which is
sourced from G. glabra. The blocker licochalcone A differs
from hesperetin and (-)-liquiritigenin by its chemical structure
and its action as a partial antagonist (Figures 3D–F, 4). The
combination of concentration-dependency and partial blocker
properties is unusual. Although these properties allude to the
action of licochalcone A as a partial agonist, this consideration
can be ruled out due to the absence of the direct activation of 5-
HT3A receptors. The hypothesis of a concentration-dependent,
allosteric antagonist whose maximal inhibition decreases with
increasing agonist concentrations is more likely.
We showed that the Glycyrrhiza uralensis tincture exhibits
the strongest inhibition of 5-HT3A receptor responses compared
with the rest of the rikkunshito constituents, possibly due to
the action of the flavonoid (-)-liquiritigenin. Other Glycyrrhiza
species share this flavonoid-based 5-HT3A receptor antagonism,
which is attributable to the antagonists glabridin and licochalcone
A, a partial 5-HT3A receptor antagonist. These results contribute
to a better understanding of the action of rikkunshito at a
pharmacological level and allow the establishment of flavonoids
as a new potent class of plant ingredients with regard to 5-
HT3 receptor antagonism. Therefore, flavonoids appear to be at
least equally active antagonists as gingerols and shogaols from
Zingiberis and ginsenosides fromGinseng, which were thought to
be responsible for the antiemetic properties of rikkunshito prior
to this study. However, it should bementioned, that the identified
antagonists are inferior to already commonly used drugs like
setrons due to their lower potency. Hence, a comparatively
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higher concentration of flavonoids must be reached to cause
physiologically relevant effects. If those concentrations of
substances with 5-HT3 receptor antagonism can be reached
by rikkunshito under naturally-occuring conditions is hard to
define. However, rikkunshito contains flavonoids, ginsenosides,
and vanilloids, three well-investigated classes of plant ingredients
that inhibit 5-HT3A receptors by binding to the receptor,
presumably at independent binding sites. Hence, a synergistic
drug interaction with additional or maybe mutual potentiating
character is conceivable. In an exemplary experiment, we
demonstrated that the combined action of distinct plant derived
blockers can lead to an increased block of the 5-HT3A receptor
(Supplementary Figure 3). In addition to that, a contribution of
structurally related, unemployed substances, e.g., liquiritin and
its apiosides and glycosides to the 5-HT3 receptor antagonism
seems to be likely. In this study, we refuted the assumption
that hesperidin, the main ingredient of rikkunshito, promotes
gastric emptying via 5-HT3 receptor antagonism due to the lack
of antagonism obtained in our screening. Instead, hesperetin, the
aglycone of hesperidin, acts as a 5-HT3A receptor antagonist.
Nevertheless, a 5-HT3 receptor mediated effect of hesperidin
is assumed due to the occurrence of deglycosylation in vivo.
This study contributes to a better understanding of the action
of rikkunshito at a pharmacological level and emphasizes the
importance of Glycyrrhiza and Aurantii for the antagonism of
5-HT3A receptors.
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